Clopidogrel

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on May 30, 2019.

Return to the list of Patented Medicine Litigation page.





Clopidogrel

PLAVIX – Sanofi-aventis Canada Inc. (NOC Search)

Patents:

  • 1194875: PHARMASCIENCE, APOTEX, COBALT
  • 1336777: APOTEX, COBALT, PHARMASCIENCE, TEVA, NOVOPHARM, RIVA, RANBAXY, SIGNA, APOTEX, , APOTEX, SIGNA, ACTAVIS, SIGNA, SANDOZ, MYLAN, DOMINION, PHARMASCIENCE
  • 2334870: PHARMASCIENCE, APOTEX, COBALT

Unknown/Other

ACTAVIS

APOTEX

APOTEX, SIGNA

COBALT

DOMINION, PHARMASCIENCE

MYLAN

NOVOPHARM

PHARMASCIENCE

RANBAXY

RIVA

SANDOZ

SIGNA

SIGNA, APOTEX

TEVA


Return to the Patented Medicine Litigation page.

Canadian Intellectual Property